Tasmina is a partner in the firm's Patent team and is a core member of the firm's UK and International Life Sciences Group.
She works with our clients in the life sciences sector advising on contentious and non-contentious areas, including a broad range of regulatory and compliance issues relating to pharmaceuticals, medical devices, food supplements, human cells and tissue. Tasmina regularly advises on patent, regulatory and contract disputes, with a particular focus on arbitrations as well as the regulatory aspects of corporate transactions. Tasmina further assists clients with specialist agreements, such as clinical trials agreements.
Next generation partner
Next generation partner
Intellectual Property - Band 2: “Tasmina is a good patent litigator.”
Intellectual Property (Next generation partner)
Product liability - defendant: "Tasmina Goraya combines impressive scientific know-how with the ability to communicate the detail to non-experts in a compelling way."
Biotechnology (Next generation partner)
IP - contentious and non-contentious
Product liability - defendant: "Tasmina Goraya combines impressive scientific know-how with the ability to communicate the detail to non-experts in a compelling way."
Halyard Health on the sale of its surgical and infection prevention (S&IP) business to OMI.
Apotex on the sale of six European subsidiaries in Belgium, Poland, the Netherlands, Czech Republic and Spain, to Aurobindo for EUR74 million. This highly complex transaction involved the share transfer of subsidiaries in multiple jurisdictions being co-ordinated and managed by our UK team. We simultaneously advised on a multitude of business separation, ongoing product supply agreements and IP licences for the European business to continue operating after being removed from the Apotex group.
A medical research organisation in a multi-million pound arbitration claim against a Japanese pharmaceutical company, seeking royalties due on the sales of a blockbuster drug resulting from an R&D collaboration between the parties.
'Femtech' – regulatory considerations
Tasmina Goraya looks at the application of medical device and healthcare law to femtech products and services.
5 / 5 观点
Graham Hann, Tasmina Goraya, and Ronald Graham discuss the future of technology, life sciences and private wealth with Legal Cheek
作者
作者 Colin McCall 以及 Charlie Adams
作者
作者 Paul Orij 以及 Andrei Babiy
作者
作者